7-10 May, 2023 | Boston Convention & Exhibition Center | Booth #1340 | Boston, MA
Contact us here for more information.
Centers for Medicare & Medicaid Services (CMS) will begin negotiating with manufacturers on the price of Medicare Part D drugs beginning this year. In September, CMS will publish the list of 10 Part D selected drugs for negotiations. A key issue in the negotiations will be determination of the fair market price for a product. ICON panelists will bring their perspectives on critical issues around support for a product’s fair market price.Watch on demand